project id: TCGA-THCA; case submitter id: TCGA-ET-A39O; source center: 23; state: released; a260 a280 ratio: 1.78; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.3; rna integrity number: 7.9; age at index: 39; days to birth: -14295; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1967; age at diagnosis: 14295; ajcc pathologic m: MX; ajcc pathologic n: N0; ajcc pathologic stage: Stage I; ajcc pathologic t: T1; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 3059.0; icd 10 code: C73; last known disease status: not reported; morphology: 8344/3; primary diagnosis: Papillary carcinoma, columnar cell; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Thyroid gland; synchronous malignancy: No; tissue or organ of origin: Thyroid gland; tumor grade: Not Reported; year of diagnosis: 2006; alcohol history: Not Reported; is ffpe: false; weight: 30.0; composition: Not Reported; days to collection: 1778; days to sample procurement: 0; initial weight: 80.0; portion submitter id: TCGA-ET-A39O-01A-11; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 10.0; percent tumor cells: 90.0; percent tumor nuclei: 82.0;